bLipid droplets (LDs) are intracellular structures that regulate neutral lipid homeostasis. In mammals, LD synthesis is inhibited by rapamycin, a known inhibitor of the mTORC1 pathway. In Saccharomyces cerevisiae, LD dynamics are modulated by the growth phase; however, the regulatory pathways involved are unknown. Therefore, we decided to study the role of the TORC1 pathway on LD metabolism in S. cerevisiae. Interestingly, rapamycin treatment resulted in a fast LD replenishment and growth inhibition. The discovery that osmotic stress (1 M sorbitol) also induced LD synthesis but not growth inhibition suggested that the induction of LDs in yeast is not a secondary response to reduced growth. The induction of LDs by rapamycin was due to increased triacylglycerol but not sterol ester synthesis. Induction was dependent on the TOR downstream effectors, the PP2A-related phosphatase Sit4p and the regulatory protein Tap42p. The TORC1-controlled transcriptional activators Gln3p, Gat1p, Rtg1p, and Rtg3p, but not Msn2p and Msn4p, were required for full induction of LDs by rapamycin. Furthermore, we show that the deletion of Gln3p and Gat1p transcription factors, which are activated in response to nitrogen availability, led to abnormal LD dynamics. These results reveal that the TORC1 pathway is involved in neutral lipid homeostasis in yeast.
Lipid droplets (LDs) are intracellular structures formed by a core of neutral lipids, mainly triacylglycerols (TAG) and sterol esters (SE), which are delimited by a phospholipid monolayer embedded with proteins primarily related to lipid metabolism (1-3). At first, LDs were believed to be mere neutral lipid deposits, but later it became clear that LDs play other important roles in cellular physiology. The main function of LDs is to maintain cellular lipid homeostasis (4, 5), and it was shown that defects in the mobilization of neutral lipids from LDs are related to type 2 diabetes, inflammation, neurodegenerative disorders, and cancer (6-8). In addition to their importance in health, LDs also are studied in oleaginous yeast for their exploitation as cellular oil factories for biofuel production (9).Although the metabolic steps of LD biogenesis are well known, the signals that govern LD dynamics are not clear yet. Because the signaling pathways are well conserved between yeast and mammals, Saccharomyces cerevisiae has been a model for studying LD dynamics. In S. cerevisiae, LDs follow a particular dynamic tightly linked to the growth phase and to the nutritional status of the cell (10, 11). When quiescent yeast cells encounter a rich medium containing glucose, cells must exit G 0 in order to start duplication and cell growth (12). This start demands a large amount of sterols and fatty acids, leading to the strong mobilization of the neutral lipids stored in LDs. As a result, LDs are diminished in number and in size (10). After this strong lipolytic phase, yeast cells shift to a lipogenic phase to replenish the levels of LDs, reaching its maximum at early stationary phase (10, 11).The regu...